More Questions About Vytorin

January 17, 2008 6:06 AM

Questions remain about FDA approval of the cholesterol drug Vytorin, why studies showing its ineffectiveness were delayed, and why the company's president unloaded stock. Susan Koeppen reports.

  • Vytorin Ads Face Congressional Scrutiny
    • Share:
    • Recommended
    • Consumers Ask it Early Consumers Ask it Early

      3:50 December 7, 2009

    • John Lithgow on Dexter John Lithgow on Dexter

      4:32 December 7, 2009

    • The Amazing Finale The Amazing Finale

      5:18 December 7, 2009

    • Best eReaders to Buy? Best eReaders to Buy?

      2:46 December 7, 2009

    • U.S. to Reduce Carbon Emissions U.S. to Reduce Carbon Emissions

      1:36 December 7, 2009

    • Amanda Knox's Parents Keep Hope Amanda Knox's Parents Keep Hope

      2:53 December 7, 2009